The comparison of GSEA in MA-treated tumors to PT+MA-treated tumors demonstrated pathways suppressed by PT, and included important pathways central to tumor progression, including oxidative phosphorylation, glycolysis, hypoxia, and mTOR signaling. This evidence concerns the gene MTOR and neoplasm.